We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$10.3B
AUM Growth
+$817M
Cap. Flow
+$647M
Cap. Flow %
6.3%
Top 10 Hldgs %
9.34%
Holding
2,856
New
754
Increased
869
Reduced
698
Closed
531

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$113M
2
TJX icon
TJX Companies
TJX
+$95.9M
3
YUM icon
Yum! Brands
YUM
+$87.7M
4
CL icon
Colgate-Palmolive
CL
+$69.2M
5
DIS icon
Walt Disney
DIS
+$68.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.03%
2 Technology 12.14%
3 Financials 10.96%
4 Healthcare 10.46%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CISN
851
DELISTED
Cision Ltd. Ordinary Share
CISN
$1.98M 0.02%
+168,517
New +$2M
FTR
852
DELISTED
Frontier Communications Corp.
FTR
$1.97M 0.02%
1,127,548
+168,297
+18% +$343K
FL
853
DELISTED
Foot Locker
FL
$1.97M 0.02%
+47,003
New +$2.44M
BOLD
854
DELISTED
Audentes Therapeutics, Inc
BOLD
$1.97M 0.02%
52,000
-16,658
-24% -$640K
TDY icon
855
Teledyne Technologies
TDY
$30.4B
$1.97M 0.02%
7,185
-23,766
-77% -$5.92M
XLV icon
856
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$1.96M 0.02%
+21,200
New +$1.91M
KW
857
DELISTED
Kennedy-Wilson Holdings
KW
$1.96M 0.02%
95,408
+81,108
+567% +$1.73M
TRN icon
858
Trinity Industries
TRN
$2.97B
$1.96M 0.02%
+94,475
New +$2.01M
UTHR icon
859
United Therapeutics
UTHR
$26.3B
$1.96M 0.02%
25,103
-11,151
-31% -$1.04M
EXTR icon
860
Extreme Networks
EXTR
$3.86B
$1.96M 0.02%
302,719
+281,480
+1,325% +$1.86M
VG
861
DELISTED
Vonage Holdings Corporation
VG
$1.96M 0.02%
172,753
-239,651
-58% -$2.59M
DELL icon
862
Dell
DELL
$283B
$1.96M 0.02%
+75,953
New +$2.37M
CUB
863
DELISTED
Cubic Corporation
CUB
$1.96M 0.02%
30,321
+20,175
+199% +$1.18M
RNR icon
864
RenaissanceRe
RNR
$13.7B
$1.95M 0.02%
+10,970
New +$1.8M
BPMC
865
DELISTED
Blueprint Medicines
BPMC
$1.95M 0.02%
20,663
-14,224
-41% -$1.17M
EBS icon
866
Emergent Biosolutions
EBS
$375M
$1.95M 0.02%
+40,312
New +$1.93M
FMBI
867
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$1.94M 0.02%
94,764
+48,899
+107% +$1.01M
CORT icon
868
Corcept Therapeutics
CORT
$10.2B
$1.93M 0.02%
173,371
+29,788
+21% +$332K
VPL icon
869
Vanguard FTSE Pacific ETF
VPL
$8.05B
$1.93M 0.02%
+29,200
New +$1.91M
GSK icon
870
GSK
GSK
$103B
$1.93M 0.02%
38,540
-751
-2% -$37.7K
LIVN icon
871
LivaNova
LIVN
$4.3B
$1.92M 0.02%
+26,644
New +$1.95M
CMA
872
DELISTED
Comerica
CMA
$1.91M 0.02%
26,279
-165,061
-86% -$12.3M
PS
873
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$1.91M 0.02%
62,942
+28,704
+84% +$922K
IT icon
874
Gartner
IT
$9.41B
$1.91M 0.02%
+11,845
New +$1.85M
WAT icon
875
Waters Corp
WAT
$36.8B
$1.9M 0.02%
8,842
+5,729
+184% +$1.25M

Similar funds

Squarepoint's Q2 2019 Portfolio in Review

As of Q2 2019, Squarepoint held 2,856 positions worth $10.3B, up 8.7% from $9.44B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Squarepoint deployed $647M of net new capital in Q2 2019, opening 754 new positions and adding to 869 existing holdings. Its largest new stake was Celgene Corp: 988,338 shares worth $91.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Dollar General, an estimated $113M trimmed.

  • Squarepoint's largest Q2 2019 buy was Celgene Corp: 988,338 shares worth $91.4M.
  • Squarepoint added most to Amazon in Q2 2019, an estimated $97.9M increase.
  • Squarepoint's biggest Q2 2019 reduction was Dollar General, cutting an estimated $113M.
  • Squarepoint fully exited iShares MSCI India ETF in Q2 2019, selling an estimated $55.7M.
  • Squarepoint's ten largest holdings make up 9.3% of its $10.3B portfolio in Q2 2019.
  • Squarepoint opened 754 new positions and closed 531 in Q2 2019.
  • Squarepoint's portfolio value rose 8.7% quarter-over-quarter to $10.3B.

Based on Squarepoint's 13F filing for Q2 2019, filed 14 Aug 2019.